Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
FALCONE, Alfredo, RICCI, Sergio, CORTESI, Enrico, PICONE, Vincenzo, VITELLO, Stefano, CHIARA, Silvana, GRANETTO, Cristina, PORCILE, Gianfranco, FIORETTO, Luisa, ORLANDINI, Cinzia, ANDREUCCETTI, Michele, MASI, Gianluca, BRUNETTI, Isa, PFANNER, Elisabetta, ALLEGRINI, Giacomo, BARBARA, Cecilia, CRINO, Lucio, BENEDETTI, Giovanni, EVANGELISTA, Walter, FANCHINI, Laura
Published in Journal of clinical oncology (01.05.2007)
Published in Journal of clinical oncology (01.05.2007)
Get full text
Journal Article
Correlation between polymorphism of TYMS gene and toxicity response to treatment with 5-fluoruracil and capecitabine
Vitello, Stefano, Di Liegro, Italia, Ricciardi, Maria Rita, Verga, Chiara, Amato, Alessandra, Schiera, Gabriella, Di Liegro, Carlo, Messina, Giuseppe, Proia, Patrizia
Published in European journal of translational myology (04.08.2020)
Published in European journal of translational myology (04.08.2020)
Get full text
Journal Article
Correlation between polymorphism of TYMS gene and toxicity response to treatment with 5-fluoruracil and capecitabine
Vitello, Stefano, Di Liegro, Italia, Ricciardi, Maria Rita, Verga, Chiara, Amato, Alessandra, Schiera, Gabriella, Di Liegro, Carlo, Messina, Giuseppe, Proia, Patrizia
Published in European journal of translational myology (04.08.2020)
Published in European journal of translational myology (04.08.2020)
Get full text
Journal Article
TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer
Borelli, Beatrice, Moretto, Roberto, Lonardi, Sara, Bonetti, Andrea, Antoniotti, Carlotta, Pietrantonio, Filippo, Masi, Gianluca, Burgio, Valentina, Marmorino, Federica, Salvatore, Lisa, Rossini, Daniele, Zaniboni, Alberto, Zucchelli, Gemma, Martignetti, Angelo, Di Battista, Monica, Pella, Nicoletta, Passardi, Alessandro, Boccaccino, Alessandra, Leone, Francesco, Colombo, Camilla, Granetto, Cristina, Vannini, Francesca, Marsico, Valentina Angela, Martinelli, Erika, Antonuzzo, Lorenzo, Vitello, Stefano, Delliponti, Laura, Boni, Luca, Cremolini, Chiara, Falcone, Alfredo
Published in ESMO open (2018)
Published in ESMO open (2018)
Get full text
Journal Article
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists
Blasi, Livio, Bordonaro, Roberto, Borsellino, Nicolò, Butera, Alfredo, Caruso, Michele, Cordio, Stefano, Liborio, Di Cristina, Ferraù, Francesco, Giuffrida, Dario, Parra, Hector Soto, Spada, Massimiliano, Tralongo, Paolo, Valenza, Roberto, Verderame, Francesco, Vitello, Stefano, Zerilli, Filippo, Piazza, Dario, Firenze, Alberto, Gebbia, Vittorio
Published in Ecancermedicalscience (15.05.2020)
Published in Ecancermedicalscience (15.05.2020)
Get full text
Journal Article
LIFE BEYOND LONG-TERM CANCER SURVIVORS: CONCERNS AND UPDATES
Paolo Tralongo, Vittorio Mattioli, Roberto Bordonaro, Franco DI Raimondo, Francesco Ferraù, Giordano Beretta, Concetta Biondo, Livio Blasi, Riccardo Bottino, Carlo Carnaghi, Simona Carnio, Amanda Casirati, Luigi Cavanna, Roberta De Angelis, Francesco de Lorenzo, Andrea Di Cataldo, Massimo Di Maio, Davide Dondi, Fabio Efficacie, Fabio Fichera, Guido Gini, Stefano Giordani, Riccardo Haupt, Elisabetta Iannelli, Gabriella Insolia, Mario Lazzaro, Lavinia Lo Curzio, Evaristo Maiello, Sandro Barni, Carmelo Nicolosi, Domenico Priolo, Elena Puzzo, Stefania Rapisardi, Daniela Respini, Giuseppe Saglio, Daniela Sambataro, Nicola Silvestris, Rosalia Maria Sorce, Alfredo Spartà, Chiara Barone, Laura Valvo, Maria Vasile, Stefano Vitello, Monica Zerilli
Published in Journal of cancer rehabilitation (01.01.2023)
Published in Journal of cancer rehabilitation (01.01.2023)
Get full text
Journal Article
Subgroup analyses in RAS mutant, BRAF mutant and all-wt mCRC pts treated with FOLFOXIRI plus bevacizumab (bev) or FOLFIRI plus bev in the TRIBE study
Loupakis, Fotios, Cremolini, Chiara, Lonardi, Sara, Tomasello, Gianluca, Ronzoni, Monica, Zaniboni, Alberto, Tonini, Giuseppe, Valsuani, Chiara, Chiara, Silvana, Boni, Corrado, Marcucci, Lorenzo, Negri, Francesca, Barone, Carlo, Vitello, Stefano, D'Amico, Mauro, Granetto, Cristina, Fontanini, Gabriella, Tomcikova, Daniela, Boni, Luca, Falcone, Alfredo
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
DPYD c.1905+1G>A and c.2846A>T and UGT1A128 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer
Del Re, Marzia, Cremolini, Chiara, Loupakis, Fotios, Marmorino, Federica, Citi, Valentina, Palombi, Marta, Bergamo, Francesca, Schirripa, Marta, Rossini, Daniele, Cortesi, Enrico, Tomasello, Gianluca, Spadi, Rosella, Buonadonna, Angela, Amoroso, Domenico, Vitello, Stefano, Di Donato, Samantha, Granetto, Cristina, D'Amico, Mauro, Danesi, Romano, Falcone, Alfredo
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Early tumor shrinkage (ETS) and deepness of response (DoR) to predict progression-free, postprogression, and overall survival: Results from the phase III TRIBE trial
Cremolini, Chiara, Loupakis, Fotios, Lonardi, Sara, Trenta, Patrizia, Antoniotti, Carlotta, Masi, Gianluca, Tomasello, Gianluca, Ronzoni, Monica, Ciuffreda, Libero, Zaniboni, Alberto, Carlomagno, Chiara, Boni, Corrado, Negri, Francesca, Barone, Carlo, Vitello, Stefano, Giuntini, Nicola, Bonetti, Andrea, D'Amico, Mauro, Boni, Luca, Falcone, Alfredo
Published in Journal of clinical oncology (20.01.2014)
Published in Journal of clinical oncology (20.01.2014)
Get full text
Journal Article
FOLFOXIRI/Bevacizumab Versus FOLFIRI/Bevacizumab as First-Line Treatment in Unresectable Metastatic Colorectal Cancer: Results of Phase III Tribe Trial by Gono Group
Cremolini, Chiara, Loupakis, Fotios, Masi, Gianluca, Lonardi, Sara, Zagonel, Vittorina, Salvatore, Lisa, Trenta, Patrizia, Tomasello, Gianluca, Ronzoni, Monica, Ciuffreda, Libero, Zaniboni, Alberto, Tonini, Giuseppe, Buonadonna, Angela, Barbara, Cecilia, Negri, Francesca V., Barone, Carlo, Vitello, Stefano, Giuntini, Nicola, Bonetti, Andrea, D'Amico, Mauro, Boni, Luca, Falcone, Alfredo
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article